Response to Xue et al, “Comment on ‘Efficacy, safety, and B-cell depletion capacity of 3 rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: A 52-week clinical trial’”
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/ts5pmvbbcn/1
下载链接
链接失效反馈官方服务：
资源简介：
Supplemental methods
